{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-21-001484","form_type":"8-K","ticker":"IGC","cik":"0001326205","company_name":"IGC Pharma, Inc.","filed_at":"2021-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.070017+00:00","generated_at":"2026-06-28T20:29:28.478341+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"IGC shareholders approve director election, ratify auditor, and authorize 3.5M share equity grant","bullets":["Richard Prins elected as Class B director, term through 2024 annual meeting.","Manohar Chowdhry & Associates ratified as independent auditor for fiscal 2022.","Board authorized grant of up to 3,500,000 common shares to employees, advisors, directors, and consultants.","Meeting turnout: 37,257,143 shares voted (≈73% of outstanding); 21,876,265 broker non-votes.","All four proposals passed; adjournment proposal was unnecessary."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-21-001484","json":"https://secwatch.observer/filing/0001185185-21-001484.json","markdown":"https://secwatch.observer/filing/0001185185-21-001484.md","text":"https://secwatch.observer/filing/0001185185-21-001484.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326205/000118518521001484/0001185185-21-001484-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326205/000118518521001484/indiaglob20211015_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:29:28.478341+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07172e414b","claim":"Richard Prins was elected as Class B director at IGC Pharma, Inc..","evidence_excerpt":"On October 15, 2021, Richard Prins was elected to India Globalization Capital’s (the “Company”) Board of Directors at the Annual Meeting, to serve as a Class B director","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326205/000118518521001484/0001185185-21-001484-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class B director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}